Financials data is unavailable for this security.
View more
Year on year PuraPharm Corp Ltd had revenues fall -9.20% from 448.07m to 406.86m, though the company grew net income from a loss of 120.21m to a smaller loss of 106.08m.
Gross margin | 51.97% |
---|---|
Net profit margin | -20.77% |
Operating margin | -12.63% |
Return on assets | -10.08% |
---|---|
Return on equity | -50.23% |
Return on investment | -30.69% |
More ▼
Cash flow in HKDView more
In 2023, cash reserves at PuraPharm Corp Ltd fell by 55.71m. However, the company earned 79.61m from its operations for a Cash Flow Margin of 19.57%. In addition the company used 18.20m on investing activities and also paid 122.39m in financing cash flows.
Cash flow per share | -0.0967 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.3296 |
---|---|
Tangible book value per share | 0.2017 |
More ▼
Balance sheet in HKDView more
Current ratio | 0.5992 |
---|---|
Quick ratio | 0.3116 |
Total debt/total equity | 3.16 |
---|---|
Total debt/total capital | 0.7597 |
More ▼